Sonoma Pharmaceuticals Inc (SNOA) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $2.93
• Market Cap: $4.96M
• EPS: $-1.95
• 52-Week High: $6.92
• 52-Week Low: $1.75

About Sonoma Pharmaceuticals Inc

Sonoma Pharmaceuticals, Inc. focuses on the development and production of stabilized hypochlorous acid (HOCl) products tailored for diverse healthcare applications, such as wound care, animal health, eye care, oral care, and dermatological treatments. Headquartered in Woodstock, Georgia, Sonoma leverages innovative technology to enhance patient outcomes across multiple international markets. With a commitment to advancing therapeutic solutions, the company is well-positioned to capitalize on ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Sonoma Pharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does SNOA pay dividends?

Sonoma Pharmaceuticals Inc (SNOA) does not currently pay a regular dividend.

What is SNOA's market cap?

Sonoma Pharmaceuticals Inc (SNOA) has a market capitalization of $4.96M with a current stock price of $2.93.